#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16406	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2132	764.8	0	.	n	.	0	C1450T	SNP	1450	1450	C	1727	1727	T	866	T	790	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	16406	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2132	764.8	1	SNP	n	C1184T	0	.	.	1184	1184	C	1461	1461	C	958	C	881	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29676	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3660	809.0	0	.	n	.	0	G1337A	SNP	1337	1337	G	1725	1725	A	969	A,G	903,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29676	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3660	809.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2359	2359	C	956	C	875	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29676	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3660	809.0	1	SNP	n	C2597T	1	C2597T	SNP	2597	2597	C	2985	2985	T	918	T,C	447,406	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	29676	23S	2890	2890	99.9	23S.l15.c30.ctg.1	3660	809.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2433	2433	A	883	A	824	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	2218	folP	852	852	99.88	folP.l15.c4.ctg.1	1524	145.2	0	.	p	.	0	E151K	NONSYN	451	453	GAA	798	800	AAA	220;218;217	A;A;A	204;202;201	.	.
folP.WHO_N_01367c	folP.WHO_N_01367c	1	1	539	2218	folP	852	852	99.88	folP.l15.c4.ctg.1	1524	145.2	1	SNP	p	R228S	1	.	.	682	684	AGC	1029	1031	AGC	222;224;223	A;G;C	205;202;197	folP.WHO_N_01367c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5966	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3309	179.7	1	SNP	p	S91F	0	.	.	271	273	TCC	565	567	TCC	213;211;210	T;C;C	191;188;189	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5966	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3309	179.7	1	SNP	p	D95N	0	.	.	283	285	GAC	577	579	GAC	196;196;199	G;A;C	181;181;186	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	5966	gyrA	2751	2751	100.0	gyrA.l15.c4.ctg.1	3309	179.7	1	SNP	p	D95G	0	.	.	283	285	GAC	577	579	GAC	196;196;199	G;A;C	181;181;186	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1910	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1304	145.5	1	SNP	p	G45D	0	.	.	133	135	GGC	503	505	GGC	233;236;236	G;G;C	221;220;220	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	898	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	938	95.0	0	.	n	.	0	A197.	DEL	197	197	A	540	540	A	198	A	185	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5728	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2792	203.8	1	SNP	p	D86N	0	.	.	256	258	GAC	476	478	GAC	227;227;228	G;A;C	212;210;211	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5728	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2792	203.8	1	SNP	p	S87R	0	.	.	259	261	AGT	479	481	AGT	229;224;225	A;G;T,C	211;208;207,1	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5728	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2792	203.8	1	SNP	p	S87W	0	.	.	259	261	AGT	479	481	AGT	229;224;225	A;G;T,C	211;208;207,1	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5728	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2792	203.8	1	SNP	p	S87I	0	.	.	259	261	AGT	479	481	AGT	229;224;225	A;G;T,C	211;208;207,1	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	27	5728	parC	2304	2304	99.91	parC.l15.c4.ctg.1	2792	203.8	1	SNP	p	S88P	0	.	.	262	264	TCC	482	484	TCC	227;228;231	T,C;C;C	211,1;212;216	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4862	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2719	178.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1586	1588	GGC	217;212;211	G;G;C	201;195;193	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1280	1282	GCA	279;281;288	G;C;A	260;257;268	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1283	1285	ATC	291;288;290	A;T;C	266;266;267	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1295	1297	GTG	289;291;289	G;T;G	263;262;259	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1295	1297	GTG	289;291;289	G;T;G	263;262;259	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1799	1801	ACC	247;247;245	A,T;C;C	220,1;227;223	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1853	1855	GCG	231;231;229	G;C;G	202;187;188	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1853	1855	GCG	231;231;229	G;C;G	202;187;188	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	1976	1978	GGC	204;205;202	G;G;C	184;184;179	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	1985	1987	GGC	203;200;201	G;G;C	176;176;176	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	4638	penA	1749	1749	100.0	penA.l15.c30.ctg.1	2528	183.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2003	2005	CTG	201;204;204	C,G;T;G,C,T	151,4;147;158,2,1	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	6376	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3076	206.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1597	1599	CCG	226;225;225	C;C;G	198;204;200	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2570	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1589	160.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	446	446	C	172	C	164	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	N38E	NONSYN	112	114	AAT	378	380	GAA	243;243;243	G;A;A	229;229;227	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	N134D	NONSYN	400	402	AAT	666	668	GAT	227;230;232	G;A;T	208;209;207	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	P175S	NONSYN	523	525	CCA	789	791	TCA	267;269;273	T;C;A	248;246;252	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	D212N	NONSYN	634	636	GAT	900	902	AAT	226;224;222	A;A;T	218;214;209	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	A218V	NONSYN	652	654	GCC	918	920	GTC	220;221;223	G;T;C	213;213;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	F222S	NONSYN	664	666	TTT	930	932	TCT	227;228;228	T;C,T;T	219;219,1;220	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	R258H	NONSYN	772	774	CGT	1038	1040	CAT	249;247;245	C;A,T;T	229;226,1;226	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	S292T	NONSYN	874	876	TCT	1140	1142	ACT	265;265;265	A;C;T	237;238;238	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1248	1250	GCA	250;251;251	G,C;C;A	233,1;236;237	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	1	SNP	p	G120K	1	.	.	358	360	AAG	624	626	AAG	227;228;228	A;A;G	210;212;211	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	1	SNP	p	D121N	0	.	.	361	363	GAC	627	629	GAC	229;226;224	G;A;C	212;208;209	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2980	porB1b	1047	1047	98.95	porB1b.l15.c17.ctg.1	1458	202.8	1	SNP	p	A121D	1	.	.	361	363	GAC	627	629	GAC	229;226;224	G;A;C	212;208;209	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	11280	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4815	233.5	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	1981	1983	AAT	291;289;286	A;A,T;T	270;266,1;265	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1220	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1033	117.5	1	SNP	p	V57M	1	.	.	169	171	ATG	549	551	ATG	267;265;263	A;T;G,T	254;251;250,1	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
